UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer Pursuant
to Rule 13a-16 or 15d-16
Under the Securities Exchange Act of 1934
For the Month of February 2019
333-206723
(Commission File Number)
P.V. Nano Cell Ltd.
(Exact name of Registrant as specified in its charter)
8 Hamasger Street
Migdal Ha’Emek, Israel 2310102
(Address of principal executive offices)
Indicate by check mark whether the registrant
files or will file annual reports under cover
Form 20-F or Form 40-F.
Form 20-F þ Form 40-F ☐
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by
Regulation S-T Rule 101(b)(1): ____
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by
Regulation S-T Rule 101(b)(7): ____
On January 31st, 2019, P.V. Nano Cell Ltd. (the “Issuer”) issued a press release announcing Sicrys Has Best Year Ever in 2018 and Anticipates Continued Growth in 2019
Exhibit Index
Exhibit No. |
Description | |
99.1 | PV Nano Cell Sicrys Has Best Year Ever in 2018 and Anticipates Continued Growth in 2019. |
1 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
P.V. Nano Cell Ltd. | ||
Date February 4th, 2019 | By: | /s/ Dr. Fernando de la Vega |
Name: Dr. Fernando de la Vega Title: Chief Executive Officer |
2 |